Lifesaving implantable defibrillators should be given to heart failure patients at highest risk of heart rhythm problems at an earlier stage in their treatment, according to a new study. The paper was ...
An independent oversight agency plans to audit Metro’s defibrillators after one failed at a station last week when a rider suffered a fatal heart attack. The Tri-State Oversight Committee, which is ...
The Resynchronization–Defibrillation for Ambulatory Heart Failure Trial (RAFT) showed a greater benefit with respect to mortality at 5 years among patients who received cardiac-resynchronization ...